Insider Transactions in Q1 2024 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2024
|
Eric Warren Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+37.27%
|
-
|
|
Mar 14
2024
|
Sheldon L. Koenig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
454,000
+37.19%
|
-
|
|
Mar 14
2024
|
Benjamin Looker General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+35.25%
|
-
|
|
Mar 14
2024
|
Joanne M. Foody Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+35.12%
|
-
|
|
Mar 14
2024
|
Benjamin Halladay Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
170,000
+41.07%
|
-
|